A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva)
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务:
资源简介:
Multicenter, open-label, phase 1, cohort dose escalation study to determine the Maximum Tolerated Dose (MTD) of OSI-906 in combination with erlotinib
创建时间:
2008-10-15



